Zusammenfassung
ICD-10-Code H16 Keratitis
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Literatur und weiterführende Literatur
Alhassan MB, Rabiu M, Agbabiaka IO (2011) Interventions for Mooren’s ulcer. Cochrane Database Syst Rev 15(6):CD006131
Atchia II, Kidd CE, Bell RW (2006) Rheumatoid arthritis-associated necrotizing scleritis and peripheral ulcerative keratitis treated successfully with infliximab. J Clin Rheumatol 12:291–293
Clewes AR, Dawson JK, Kaye S, Bucknall RC (2005) Peripheral ulcerative keratitis in rheumatoid arthritis: successful use of intravenous cyclophosphamide and comparison of clinical and serological characteristics. Ann Rheum Dis 64:961–962
Constantinou M, Jhanji V, Tao LW, Vajpayee RB (2009) Clinical review of corneal ulcers resulting in evisceration and enucleation in elderly population. Graefes Arch Clin Exp Ophthalmol 247:1389–1393
Daniel Diaz J, Sobol EK, Gritz DC (2016) Treatment and management of scleral disorders. Surv Ophthalmol 61:702–717
Diogo MC, Jager MJ, Ferreira TA (2016) CT and MR imaging in the diagnosis of scleritis. AJNR Am J Neuroradiol 37:2334–2339
Dominguez-Casas LC, Sánchez-Bilbao L, Calvo-Río V et al. (2020) Biologic therapy in severe and refractory peripheral ulcerative keratitis (PUK). Multicenter study of 34 patients. Semin Arthritis Rheum 50:608–615
Doshi RR, Harocopos GJ, Schwab IR, Cunningham ET Jr (2013) The spectrum of postoperative scleral necrosis. Surv Ophthalmol 58(6):620–633
Feist E, Pleyer U (2010) Erkrankungen des äußeren Auges bei rheumatoider Arthritis. Z Rheumatol 69:403–410
Foster CS, Forstot SL, Wilson LA (1984) Mortality rate in rheumatoid arthritis patients developing necrotizing scleritis or peripheral ulcerative keratitis. Effects of systemic immunosuppression. Ophthalmology 91:1253–1263
Goodisson LA, Bourne JT, Maharajan S (2010) A case of bilateral peripheral ulcerative keratitis following treatment with rituximab. Rheumatology 49:609–610
Gottsch JD, Akpek EK (2000) Topical cyclosporin stimulates neovascularization in resolving sterile rheumatoid central corneal ulcers. Trans Am Ophthalmol Soc 98:81–87
Kuroda Y, Uji A, Morooka S, Nishijima K, Yoshimura N (2017) Morphological features in anterior scleral inflammation using swept-source optical coherence tomography with multiple B-scan averaging. Br J Ophthalmol 101:411–417
Lee YJ, Kim SW, Seo KY (2013) Application for tacrolimus ointment in treating refractory inflammatory ocular surface diseases. Am J Ophthalmol 155(5):804–813
Müller L, Thiel MA, Kipfer-Kauer AI, Kaufmann C (2012) Corneal cross-linking as supplementary treatment option in melting keratitis: a case series. Klin Monatsbl Augenheilkd 229:411–415
Odorcic S, Keystone EC, Ma JJ (2009) Infliximab for the treatment of refractory progressive sterile peripheral ulcerative keratitis associated with late corneal perforation: 3-year follow-up. Cornea 28:89–92
Pleyer U, Mondino BJ, Sumner HL (1992) The effect of systemic decomplementation with cobra venom factor on corneal complement levels in guinea pigs. Invest Ophthalmol Vis Sci 33(7):2212–2215
Pleyer U, Bertelmann E, Rieck P, Hartmann C (2002) Outcome of penetrating keratoplasty in rheumatoid arthritis. Ophthalmologica 216:249–255
Pohlmann D, Pleyer U (2018) Skleritis – Fortschritte zur Diagnose und Therapie Klin Monbl Augenheilkd 235:603–610
Pohlmann D, Winterhalter S, Pleyer U (2018) Intravitreal Dexamethasone for the Treatment of CMO Associated with Refractory Sclerouveitis. Ocul Immunol Inflamm 26:160–165
Reynolds I, Tullo AB, John SL, Holt PJ, Hillarby MC (1999) Corneal epithelial-specific cytokeratin 3 is an autoantigen in Wegener’s granulomatosis-associated peripheral ulcerative keratitis. Invest Ophthalmol Vis Sci 40(9):2147–2151
de la Sainz Maza M, Foster CS, Jabbur NS, Baltatzis S (2002) Ocular characteristics and disease associations in scleritis-associated peripheral keratopathy. Arch Ophthalmol 120:15–19
Singh A, Tandon R, Sangwan VS (2017) Medical therapy algorithms. In: Tandon R, Galor A, Sangwan V, Ray M (Hrsg) Peripheral ulcerative keratitis essentials in ophthalmology. Springer, Cham
Smith VA, Hoh HB, Easty DL (1999) Role of ocular matrix metalloproteinases in peripheral ulcerative keratitis. Br J Ophthalmol 83:1376–1383
Spoerl E, Wollensak G, Seiler T (2004) Increased resistance of crosslinked cornea against enzymatic digestion. Curr Eye Res 29:35–34
Tandon R, Chawla B, Verma K, Sharma N, Titiyal JS (2008) Outcome of treatment of mooren ulcer with topical cyclosporine a 2 %. Cornea 27(8):859–861
Thomas JW, Pflugfelder SC (2005) Therapy of progressive rheumatoid arthritis-associated corneal ulceration with infliximab. Cornea 24:742–744
Turk MA, Hayworth JL, Nevskaya T, Pope JE (2021) Ocular Manifestations in Rheumatoid Arthritis, Connective Tissue Disease, and Vasculitis: A Systematic Review and Metaanalysis. J Rheumatol 48:25–34
Watson PG (1990) Vascular changes in peripheral corneal destructive disease. Eye 4:65–73
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature
About this chapter
Cite this chapter
Pleyer, U. (2021). Periphere Hornhautulzeration (engl. peripheral ulcerative keratitis [PUK], marginal corneal ulceration). In: Pleyer, U. (eds) Entzündliche Augenerkrankungen. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-60399-4_16
Download citation
DOI: https://doi.org/10.1007/978-3-662-60399-4_16
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-60398-7
Online ISBN: 978-3-662-60399-4
eBook Packages: Medicine (German Language)